Mead Johnson

Last updated

Mead Johnson & Company, LLC
Company type Subsidiary (LLC)
IndustryPediatric nutrition
Founded1905;119 years ago (1905)
Founder Edward Mead Johnson
Headquarters River Point, Chicago, Illinois
Evansville, Indiana
(Global Operations Center)
Area served
Worldwide
Key people
Aditya Sehgal, EVP Infant and Child Nutrition
Number of employees
7,500 (2017)
Parent Reckitt
Website www.meadjohnson.com

Mead Johnson & Company, LLC is an American company that is a leading manufacturer of infant formula, both domestically and globally, with its flagship product Enfamil. It operates as an independent subsidiary of Reckitt.

Contents

The company dates back to a firm created by Edward Mead Johnson, one of the co-founders of Johnson & Johnson, who created his own business in 1895, which was renamed Mead Johnson & Company in 1905. The company was majority owned by Bristol-Myers Squibb after an acquisition in 1967, but was spun-off in 2009 as an independent firm. Almost products were used by infants and children under 7, But Enfaschool which covers students from childhood to youth under 15 years.

In the year end December 31, 2016, Mead Johnson reported net sales of $3,743 million. Fifty percent of those sales were generated in Asia, 17% in Latin America and 33% in North America/Europe. For the same time period, the company reported total assets of $4,088 million.

In February 2017, British consumer goods company Reckitt (then known as Reckitt Benckiser at the time) bid $16.7 billion for the company. [1] On June 15, 2017, MJN announced that its merger with RB has been completed. As a result, MJN's common stock is no longer traded on the New York Stock Exchange, effective the announcement date. [2]

History and products

Dextri-Maltose and Pablum, early Mead Johnson products Pablum etc - Indiana State Museum - DSC00438.JPG
Dextri-Maltose and Pablum, early Mead Johnson products

Edward Mead Johnson had founded Johnson & Johnson in 1886 together with his brothers. In 1895, Johnson developed a side business called The American Ferment Company to create a digestive aid. In 1897, E. Mead Johnson left the family business to go out into business on his own in Jersey City, New Jersey, and in 1905, the company was re-established as Mead Johnson & Company. [3] The firm's first major infant formula was developed in 1910, and Dextri-Maltose, a carbohydrate-based milk modifier was introduced in 1911, making it the first American product for infants to be clinically approved and recommended by doctors. The firm moved to Evansville, Indiana, in 1915, in the wake of World War I, as part of an effort to have easier access to the raw agricultural ingredients that were needed for its products, which required Johnson to build a series of new plants and factories to replace the ones he had left behind in New Jersey. [3]

Edward Mead Johnson died in 1934, and Lambert Mead Johnson succeeded his father as president, and served in the position until 1955, making him the longest-serving president in company history. [3] D. Mead Johnson was the third generation of the family to serve as chief executive of the firm. During his tenure, which lasted from 1955 until the firm's takeover by Bristol-Myers in 1968, the firm's annual sales tripled to $131 million, and grew to nearly 4,400 employees. [4]

Acquisition and spin-off from Bristol-Myers

Bristol-Myers reached agreement in August 1964 for a deal under which Mead Johnson would be acquired, with shareholders receiving a mix of common and preferred stock in a deal valued at $240 million. Mead Johnson's net sales in 1966 were $131 million with earnings of $7.3 million. [5]

Bristol-Myers announced in February 2009 that it was going to spin off Mead Johnson to focus on its primary pharmaceutics business, with an initial public offering estimated to bring in $562.5 million and would leave Bristol-Myers with 90% ownership of the firm. [6] A plan offered in November 2009 would allow shareholders of Bristol-Myers to exchange one dollar of stock in that company for $1.11 worth of shares in Mead Johnson for the 133.5 million shares in the firm, which would value the company at $7.7 billion based on the stock's then current closing price. The stock swap was intended to provide a tax-free exchange. CEO James M. Cornelius of Bristol-Myers said that "With a successful execution of this split-off, we fully consider ourselves a BioPharma company". [7]

Acquisition by Reckitt Benckiser

In February 2017 it was announced that Reckitt Benckiser (RB) was in advanced negotiations to acquire Mead Johnson. [8] [9] On February 10, 2017, Reckitt Benckiser Group announced it had agreed to buy Mead Johnson Nutrition Co. for $16.6 billion. [10]

RB's intention was to acquire Mead Johnson Nutrition for $90 per share in cash. In order to effect the transaction, RB incorporated a subsidiary in Delaware into which Mead Johnson Nutrition has merged, with Mead Johnson Nutrition being the surviving entity at completion. [11]

Mead Johnson announced on June 12, 2017, that the final regulator approval to complete the acquisition had been received. On June 15, 2017, the merger was completed and Mead Johnson became the Infant Formula and Child Nutrition (IFCN) Division of RB.

Related Research Articles

<span class="mw-page-title-main">Nestlé</span> Swiss multinational food company

Nestlé S.A. is a Swiss multinational food and drink processing conglomerate corporation headquartered in Vevey, Switzerland. It has been the largest publicly held food company in the world, measured by revenue and other metrics, since 2014. It ranked No. 64 on the Fortune Global 500 in 2017. In 2023, the company was ranked 50th in the Forbes Global 2000.

<span class="mw-page-title-main">Danone</span> French multinational food corporation

Danone S.A. is a French multinational food-products corporation based in Paris. It was founded in 1919 in Barcelona, Spain. It is listed on Euronext Paris, where it is a component of the CAC 40 stock market index. Some of the company's products are branded Dannon in the United States.

<span class="mw-page-title-main">Bristol Myers Squibb</span> American pharmaceutical company

The Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb (BMS), is an American multinational pharmaceutical company. Headquartered in Princeton, New Jersey, BMS is one of the world's largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations. For fiscal 2022, it had a total revenue of $46.2 billion.

<span class="mw-page-title-main">FTSE 100 Index</span> British stock market index

The Financial Times Stock Exchange 100 Index, also called the FTSE 100 Index, FTSE 100, FTSE, or, informally, the "Footsie", is the United Kingdom's best-known stock market index of the 100 most highly capitalised blue chips listed on the London Stock Exchange.

<span class="mw-page-title-main">SSL International</span> British company

SSL International plc was a British manufacturer of healthcare products. Its best known brands were Durex and Scholl; other significant brands were Sauber and Mister Baby. The company's name was an abbreviation of Seton Scholl London International, its predecessor businesses. The company was founded in 1929 and was listed on the London Stock Exchange. In November 2010, SSL International was folded into Reckitt.

<span class="mw-page-title-main">Reckitt</span> British-Dutch multinational consumer goods company

Reckitt Benckiser is a British-Dutch multinational consumer goods company headquartered in Slough, United Kingdom, and Hoofddorp, Netherlands. It is a producer of health, hygiene and nutrition products. The company was formed in 1999 by the merger of British company Reckitt & Colman plc and Dutch company Benckiser N.V.

<span class="mw-page-title-main">Celgene</span> American biopharmaceutical company

Celgene Corporation is a pharmaceutical company that makes cancer and immunology drugs. Its major product is Revlimid (lenalidomide), which is used in the treatment of multiple myeloma, and also in certain anemias. The company is incorporated in Delaware, headquartered in Summit, New Jersey, and a subsidiary of Bristol Myers Squibb (BMS).

<span class="mw-page-title-main">Perrigo</span> Irish tax-registered pharmaceutical

Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters in Grand Rapids, Michigan, within Michigan State University's Grand Rapids Innovation Park.

<span class="mw-page-title-main">Evercore</span> American financial services company

Evercore Inc., formerly known as Evercore Partners, is a global independent investment banking advisory firm founded in 1995 by Roger Altman, David Offensend, and Austin Beutner. The firm has advised on over $4.7 trillion of merger, acquisition, and restructuring transactions since its founding. Evercore is widely considered one of the most prestigious and elite investment banking advisory firms.

Guangdong Yashili Group Co., Ltd. is a leading privately owned infant formula and soymilk products company in China. Based in Chaoan in the Chaozhou region of the Guangdong Province, China and, incorporated in the Cayman Islands. The company also has a Hong Kong-listed entity Yashili International Holdings Limited.

Lambertus Johannes Hermanus "Bart" Becht is a Dutch businessman. An executive with more than 35 years of business experience working with consumer brands, Becht is the former Chief Executive Officer of Reckitt, which he led from 1995 to 2011 and former Partner at JAB Holding Company, which he joined in 2012. Becht announced his retirement from JAB in 2019.

<span class="mw-page-title-main">Dr. Scholl's</span> Footwear and foot care brand

Dr. Scholl's is a footwear and orthopedic foot care brand originating in the United States, marketed in some countries as simply "Scholl". Since 2021, global rights to the brand have been owned by investment firm Yellow Wood Partners through subsidiary Scholl's Wellness Company, having purchased the North American rights from Bayer in North America in 2019, and the international rights from Reckitt in 2021.

<span class="mw-page-title-main">Wyeth</span> American pharmaceutical company

Wyeth was a pharmaceutical company until it was purchased by Pfizer in 2009. The company was founded in Philadelphia, Pennsylvania, in 1860 as John Wyeth and Brother. Its headquarters moved to Collegeville, Pennsylvania, and Madison, New Jersey, before its headquarters were consolidated with Pfizer's in New York City after the 2009 merger.

Nicandro Durante is a Brazilian businessman who served as the chief executive officer (CEO) of British American Tobacco (BAT), the world's largest tobacco company by sales, from 2011 to 2019. In September 2022 he was appointed as temporary CEO of Reckitt Benckiser.

Rakesh Kapoor is an Indian businessman. He was, until September 2019, chief executive (CEO) of Reckitt plc, a UK FTSE-listed multinational consumer goods company, a major producer of health, hygiene and home products.

Reckitt and Sons was a leading British manufacturer of household products, notably starch, black lead, laundry blue, and household polish, and based in Kingston upon Hull.

<span class="mw-page-title-main">Greenhill & Co.</span> American investment bank

Greenhill & Co., Inc. is an American investment banking advisory firm founded in 1996 by Robert F. Greenhill. The firm provides advice on significant mergers, acquisitions, restructurings, financings, and capital raisings to leading corporations, partnerships, institutions and governments across a number of industries. Since its inception, Greenhill has advised on transactions valued at close to $3 trillion.

Indivior is a specialty pharmaceuticals business. Established as a division of Reckitt Benckiser in 1994 and demerged from that company in December 2014, the company has been fined for false marketing claims about the safety of its drug, Suboxone. It is listed on the London Stock Exchange and on the NASDAQ Global Select Market.

Catalent, Inc. is a multinational corporation headquartered in Somerset, New Jersey. It is a global provider of delivery technologies, development, drug manufacturing, biologics, gene therapies and consumer health products. It employs more than 14,000 people, including approximately 2,400 scientists and technicians. In fiscal year 2020, it generated over $3 billion in annual revenue.

Primavera Capital Group is a Chinese investment firm with offices in Hong Kong, Beijing, Silicon Valley and Singapore. It is considered one of China's leading investment firms with notable investments in companies such as Alibaba, Ant Group, ByteDance, XPeng, Yum China and The Princeton Review.

References

  1. ↑ "Deals of the day-Mergers and acquisitions | Reuters". Reuters . February 2, 2017. Archived from the original on April 9, 2017. Retrieved April 10, 2017. Reuters Deals
  2. ↑ "Mead Johnson Nutrition Merger with Reckitt Benckiser Completed". yahoo.com. Archived from the original on January 28, 2018. Retrieved April 26, 2018.
  3. 1 2 3 Our History Archived September 1, 2012, at the Wayback Machine , Mead Johnson & Company. Accessed September 1, 2010.
  4. ↑ Saxon, Wolfgang. "D. M. Johnson, 78; Led Mead Johnson In Rapid Expansion" Archived August 19, 2016, at the Wayback Machine , The New York Times , January 23, 1993. Accessed September 1, 2010.
  5. ↑ Reckert, Clare M. "Exchange of Stock Set; MERGER DEAL SET BY BRISTOL-MYERS" Archived May 24, 2013, at the Wayback Machine , The New York Times , August 25, 1967. Accessed September 1, 2010.
  6. ↑ Staff. "Mead Johnson Set to Test I.P.O. Waters" Archived February 6, 2010, at the Wayback Machine , The New York Times , February 10, 2009. Accessed September 1, 2010.
  7. ↑ Staff. "Bristol-Myers to Split Off Mead Johnson Nutrition" Archived March 12, 2010, at the Wayback Machine , The New York Times , November 16, 2009. Accessed September 1, 2010.
  8. ↑ Thomas Mulier and Paul Jarvis (February 1, 2017). "Reckitt Targets Mead Johnson With Surprise $16.7 Billion Bid". Bloomberg. Archived from the original on February 2, 2017. Retrieved February 2, 2017.
  9. ↑ Dana, Mattioli; Dana, Cimilluca (February 1, 2017), Reckitt Benckiser Is in Talks to Buy Mead Johnson, New York City: Wall Street Journal, archived from the original on February 2, 2017, retrieved January 4, 2017
  10. ↑ Chaudhuri, Saabira (February 10, 2017), Reckitt Benckiser to Buy Mead Johnson for $16.6 Billion, The Wall Street Journal, archived from the original on February 11, 2017, retrieved February 12, 2017
  11. ↑ "Commission Decision 08-M-008 2017: Acquisition by Reckitt Benckiser Group Plc. of Mead Johnson Nutrition Company - Philippine Competition Commission". phcc.gov.ph. Archived from the original on April 26, 2018. Retrieved May 8, 2017.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.